According to ResMed's latest financial reports the company's current EPS (TTM) is $6.16. In 2022 the company made an earnings per share (EPS) of $5.52 an increase over its 2021 EPS that were of $3.58.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $6.16 | 11.59% |
2022 | $5.52 | 54.19% |
2021 | $3.58 | -25.88% |
2020 | $4.83 | 52.37% |
2019 | $3.17 | 0.63% |
2018 | $3.15 | 55.94% |
2017 | $2.02 | -12.17% |
2016 | $2.30 | -7.63% |
2015 | $2.49 | -0.4% |
2014 | $2.50 | 9.65% |
2013 | $2.28 | 12.32% |
2012 | $2.03 | -10.18% |
2011 | $2.26 | 58.6% |
2010 | $1.42 | 23.91% |
2009 | $1.15 | 44.65% |
2008 | $0.80 | 96.3% |
2007 | $0.40 | -41.3% |
2006 | $0.69 | 35.29% |
2005 | $0.51 | 9.68% |
2004 | $0.46 | 20% |
2003 | $0.39 | 27.05% |
2002 | $0.30 | 159.57% |
2001 | $0.12 | -43.37% |
2000 | $0.21 | 25.76% |
1999 | $0.16 | 45.05% |
1998 | $0.11 | 54.24% |
1997 | $0.07375 | 28.26% |
1996 | $0.05750 |